BTIG Initiates Nektar Therapeutics(NKTR.US) With Buy Rating, Announces Target Price $4
Nektar Therapeutics Analyst Ratings
Analysts Conflicted on These Healthcare Names: Nektar Therapeutics (NKTR) and BioNTech SE (BNTX)
Nektar Therapeutics Analyst Ratings
Jefferies Maintains Hold on Nektar Therapeutics, Raises Price Target to $1
Jefferies Adjusts Nektar Therapeutics Price Target to $1 From $0.50, Maintains Hold Rating
Nektar Therapeutics Analyst Ratings
Nektar Therapeutics Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcus Biosciences (RCUS), Aligos Therapeutics (ALGS) and Nektar Therapeutics (NKTR)
Nektar Therapeutics (NKTR) Gets a Sell From Bank of America Securities
Nektar Therapeutics Analyst Ratings
Mizuho Securities Sticks to Their Hold Rating for Nektar Therapeutics (NKTR)
SVB Securities Sticks to Its Hold Rating for Nektar Therapeutics (NKTR)
Jefferies Upgrades Nektar Therapeutics (NKTR) to a Hold
Mizuho Securities Sticks to Its Hold Rating for Nektar Therapeutics (NKTR)
SVB Securities Reaffirms Their Hold Rating on Nektar Therapeutics (NKTR)
Mizuho Securities Reaffirms Their Hold Rating on Nektar Therapeutics (NKTR)
SVB Securities Sticks to Its Hold Rating for Nektar Therapeutics (NKTR)
Goldman Sachs Remains a Sell on Nektar Therapeutics (NKTR)
Analyst Ratings for Nektar Therapeutics